Followers | 867 |
Posts | 35878 |
Boards Moderated | 8 |
Alias Born | 03/22/2016 |

Tuesday, November 12, 2024 4:13:54 PM
Recent KAPA News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2025 09:05:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 12:20:35 PM
- Kairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting • Business Wire • 06/03/2025 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 10:34:20 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 05/06/2025 04:20:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2025 09:28:41 PM
- Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting • Business Wire • 04/28/2025 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/25/2025 09:13:47 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/25/2025 04:15:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2025 12:30:09 PM
- Kairos Pharma Ltd. Provides Letter to Stockholders • Business Wire • 04/24/2025 12:00:00 PM
- Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer • Business Wire • 04/17/2025 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2025 09:30:06 PM
- Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer • Business Wire • 03/31/2025 11:00:00 AM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/28/2025 08:10:08 PM
- Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events • Business Wire • 03/27/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2025 11:30:31 AM
- Kairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung Cancer • Business Wire • 03/20/2025 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 12:05:18 PM
- Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds’ Potential as Therapeutics for Melanoma and Glioblastoma • Business Wire • 02/26/2025 12:00:00 PM
- Kairos Pharma Announces New Department of Defense Funding for Research of ENV205 • Business Wire • 02/18/2025 01:30:00 PM
- Kairos Pharma Adds Huntsman Cancer Institute for Phase 2 ENV105 Clinical Trial • Business Wire • 02/11/2025 01:30:00 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/10/2025 09:45:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2025 02:00:23 PM
- Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound’s Potential as a Therapeutic for Melanoma and Glioblastoma • Business Wire • 02/06/2025 01:30:00 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM